کارخانجاتداروپخش
دارو | Stocks - Tehran Stock Exchange (TSE)
داروهای شیمیایی و گیاهی
Sector:
داروهای شیمیایی و گیاهی
Market Type:
Stocks
Status:
Authorized
Last Price: 9,500 0.42
Close Price: 9,300
Cash Flow
AGM
Interim
2026/05/18 Fiscal Year 2026/03/2012 Month | 2026/05/16 Fiscal Year 2026/03/2012 Month / Audited | ||
|---|---|---|---|
Cash Generated from Operations | 8.562 Trillion | 8.609 Trillion | |
Income Taxes Paid | -1.651 Trillion | -1.651 Trillion | |
Net Cash Flow from Operating Activities | 6.911 Trillion | 6.958 Trillion | |
Proceeds from Sale of Property, Plant and Equipment | 989 Million | 989 Million | |
Purchases of Property, Plant and Equipment | -450.82 Billion | -450.82 Billion | |
Purchases of Intangible Assets | -1.373 Billion | -1.373 Billion | |
Dividends Received | 12.231 Billion | 12.231 Billion | |
Cash Received from Income on Other Investments | 5.782 Billion | 5.782 Billion | |
Net Cash Flow from Investing Activities | -433.191 Billion | -433.191 Billion | |
Net Cash Flow before Financing Activities | 6.478 Trillion | 6.525 Trillion | |
Cash Received from Borrowings | 26.51 Trillion | 26.51 Trillion | |
Repayments of Borrowings (Principal) | -25.815 Trillion | -25.815 Trillion | |
Interest Paid on Borrowings | -6.043 Trillion | -6.043 Trillion | |
Dividends Paid | -1.267 Trillion | -1.315 Trillion | |
Net Cash Flow from Financing Activities | -6.615 Trillion | -6.662 Trillion | |
Net Increase (Decrease) in Cash | -137.62 Billion | -137.62 Billion | |
Cash at Beginning of Period | 723.391 Billion | 723.391 Billion | |
Effect of Exchange Rate Changes | 82.497 Billion | 82.497 Billion | |
Cash at End of Period | 805.888 Billion | 805.888 Billion | |
Non-Cash Transactions | 600 Billion | 600 Billion |